Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Stomach cancer
Closed
Phase 2
This trial is looking at a drug called AUY922 for stomach cancer that has spread to other parts of the body (advanced stomach cancer).
Doctors often treat advanced stomach cancer with chemotherapy. But the cancer can come back again after treatment. If this happens, you may have more chemotherapy, but researchers are looking for new treatments to help people in this situation. In this trial, they are looking at a new drug called AUY922.
We know from laboratory research that AUY922 can block the activity of an called ATPase. ATPase is involved when cells divide. Blocking it may stop cancer cells growing.
In this trial, researchers will compare AUY922 with the chemotherapy drugs docetaxel and irinotecan. The aims of the trial are to
See if AUY922 helps people with advanced stomach cancer more than one of the chemotherapy drugs
Find out more about AUY922 and what happens to it in the body
Learn more about the side effects
Recruitment start: 7 October 2010
Recruitment end: 13 March 2011
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Ian Chau
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Novartis
Last reviewed: 08 May 2012
CRUK internal database number: 7054